Latest News
04 Jan
fed dl ny fed williams us central bank bonds fx finance markets
Wednesday preview: US jobs data, Services PMIs in focus

The market spotlight on Wednesday was likely to be on the so-called JOLTS labour market survey in the US.

03 Jan
dl hotel chocolat aim premium chocolate brand retailer manufacturer cocoa cacao logo
Hotel Chocolat inks partnership with Japan's Eat Creator

Premium confectioner Hotel Chocolat has signed a new strategic partnership agreement with Tokyo-based Eat Creator Corporation, it announced on Tuesday.

03 Jan
dl victorian plumbing aim bathroom fittings retailer online e commerce plumbing logo
Victorian Plumbing signs up for new distribution centre

Bathroom retailer Victorian Plumbing has signed an agreement to enter into a 20-year lease for a new, 544,000 square foot, purpose-built distribution centre in Lancashire, it announced on Tuesday, near to its existing operations.

03 Jan
dl bidstack aim advertising technology computing video game gaming logo
Bidstack launches legal action against 'non-paying' partner

In-game marketing technology company Bidstack said on Tuesday that, under the commercial agreement with Azerion Technology announced on 17 December 2021, it had performed its obligations and issued invoices which it expected would meet market expectations for the 2022 financial year.

03 Jan
dl helium one global aim helium exploration development rukwa logo
Helium One shares slide as rig deal falls through

Helium One Global said on Tuesday that the current operator of the Exalo drill rig in southern Africa had amended their contract with Exalo to allow for an extension of their operations for a period of up to 12 months.

03 Jan
dl challenger energy group plc aim energy oil gas and coal offshore drilling and other services logo
Challenger upbeat on read-across from Uruguay licensing round

Caribbean and Americas-focussed oil and gas company Challenger Energy updated the market on recent regional developments on Tuesday, noting that Uruguay's national energy company Ancap announced on 27 December that a further two offshore blocks had been awarded following competitive bids in its second 2022 open round.

03 Jan
dl genincode aim gen in code genetics testing predictions technology high cholesterol cardiovascular disease logo
GENinCode prepares for US revenue as California licence granted

Predictive genetics specialist GENinCode announced California state licensing approval and CLIA certification of its Irvine laboratory on Tuesday, enabling it to provide its products for the risk assessment of cardiovascular disease (CVD) to patients across 49 states in the US.

03 Jan
dl euro ecb european central bank europe eurozone common currency area eu eur sign pb
Europe close: Stocks rise, helped by latest inflation and jobs numbers out of Germany

The new-year rally in European shares continued on Tuesday helped by better than expected inflation and labour market data from Germany.

03 Jan
construction dl
US construction spending rises in November

Outlays on construction in the US grew by more than expected in November even as public sector spending and on residential construction fell.

03 Jan
03 Jan
dl city of london river thames square mile financial district office buildings walkie talkie gherkin cheesegrater winter night cold dark unsplash
London close: Stocks start year with positive session

Stocks in London managed a positive finish to the first trading session of the year, helped by a drop in sterling and amid optimism around the reopening of the Chinese economy.

03 Jan
03 Jan
federal reserve dl bonds us usa dollar fx
Ex-Fed's Dudley says US recession likely, but probably will not be severe

An economic recession in the US, while likely, would probably not be severe, a former top Federal Reserve official reportedly said.

03 Jan
dl hutchmed china aim pharmaceuticals drug medicine research development logo
Hutchmed China completes enrolment for solveplenib clinical trial

Hutchmed China announced on Tuesday that it has completed patient enrollment for ‘ESLIM-01’, a pivotal phase 3 clinical trial of sovleplenib for the treatment of adult patients with primary immune thrombocytopenia (ITP) in China.

03 Jan
dl greencoat renewables aim wind investment energy renewable power electricity logo
Greencoat Renewables to buy chunk of Butendiek wind farm

Greencoat Renewables has agreed to acquire 22. 5% of the Butendiek offshore wind farm in Germany from Marguerite Pantheon, it announced on Tuesday.

03 Jan
germany dl berlin bundestag
German unemployment surprises to the downside in December

Germany's labour market continued to exhibit resilience last month, possibly due in part to companies' reluctance to lay off workers.

03 Jan
dl wall street wall st new york city new york stock exchange nyse dow jones nasdaq street sign nyc united states usa america pb
US open: Major indies kick off 2023 with modest losses

Wall Street stocks were little changed on Tuesday as market participants continue to search for direction in 2023.

03 Jan
dl manufacturing industry factory production output generic pb
US factory conditions deteriorate at fastest pace in over 2 years in December, S&P Global says

Operating conditions in the US manufacturing sector recorded their steepest drop at the end of 2022 since may 2020, revised survey readings showed.

03 Jan
dl hikma pharmaceuticals logo pharma drugs medical research and development ftse 100 min
Hikma launches generic narcolepsy solution in US

Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals’ ‘Xyrem 1’, or sodium oxybate oral solution, it announced on Tuesday.

03 Jan
dl arden partners the ince group aim merger logos
Ince gets FCA nod for disposal of Arden Partners

Ince Group updated the market on its disposal of Arden Partners on Tuesday, reporting that it had now received the approval of the Financial Conduct Authority (FCA).

News Source: © 2024 Web Financial Group (UK) Limited. All rights reserved and terms of use apply.

Important Legal Notice about News Sources: Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news and we may not share the views of the author or publisher. We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.

The value of investments can fall and you may get back less than you invested.

 

Important Legal Notice about News Sources

Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news articles and we may not share the views of the author or publisher.

We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.

The value of investments can fall and you may get back less than you invested.